Carta Healthcare

Overview
News
Hospital Management?
Product stageSegments
Early
?
Healthcare analytics and business intelligence software
?

Carta healthcare is a San Francisco-based provider of clinical data management solutions founded in 2017. The company offers three main products - Atlas, Navigator, and Semaphore, powered by its Cartographer analytics platform. Atlas is an AI-powered data abstraction tool that helps hospitals submit patient data to clinical registries efficiently and accurately. Navigator analyzes healthcare organizations' data to provide recommendations for improving operational workflows. Semaphore, introduced in September 2022, is a development platform that enables healthcare organizations to create custom data science tools and AI models.

Carta's technology uses AI to streamline data entry tasks, reducing the administrative burden on nurses and clinicians. The AI replicates the work of data abstractors, allowing healthcare professionals to spend more time on patient care. However, Carta's approach involves a combination of AI and human verification, as clinician input is required for certain data fields to maintain accuracy.

Carta's solutions have been deployed across 245 hospitals within 18 health systems as of November 2022, including Stanford healthcare, Mass General Brigham, CommonSpirit Health, and UCSF Health. The company has demonstrated cost savings for its customers, with Stanford healthcare reportedly saving USD 4 million by optimizing surgical supply management using Carta's technology.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
2443 Fillmore St Unit #380-17156 San Francisco CA USA
Founded year:
2017
Employees:
101-250
IPO status:
Private
Total funding:
USD 42.3 mn
Last Funding:
USD 5.0 mn (Series B; Jun 2023)
Last valuation:
USD 6.0 mn (Aug 2017)
Key competitors
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.